GLP-1 Receptor Agonists: Geometric Series, Exponential Decline, and a Hypothetical Preoperative Management Strategy

According to the current practice guideline released on 10/29/24, most patients can continue GLP-1 RA therapy perioperatively; however, point-of-care ultrasound (POCUS) examinations have found solids or liquids retained in their stomachs despite adherence to this recommendation. While the guideline aims to streamline perioperative care, it may inadvertently increase anesthesia risk in certain patients. This paper demonstrates that many patients retain stomach contents despite discontinuing GLP-1 RA therapy for up to two weeks, and proposes a new dosing strategy to minimize anesthetic aspiration risk while limiting therapy interruption. Geometric series, exponential decline, and pharmacokinetic principles were applied to develop this schedule, based on the premise that medications are considered cleared after approximately four half-lives. Since the half-lives of semaglutide and liraglutide are approximately one week and 13 hours, respectively, we propose switching patients from semaglutide to liraglutide four weeks before surgery, then discontinuing liraglutide two days before surgery — timing that allows medication levels to decline by the full four half-lives. This strategy minimizes residual drug levels, reduces gastric retention, and lowers aspiration risk, all while limiting the overall interruption of GLP-1 RA therapy.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-16
DOI
https://doi.org/10.7759/cureus.119766
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GLP-1 Receptor Agonists: Geometric Series, Exponential Decline, and a Hypothetical Preoperative Management Strategy

Chihjen Lee, Keira Beisel
4 links
Cureus
Diabetes Treatment and Management
article

GLP-1 Receptor Agonists: Geometric Series, Exponential Decline, and a Hypothetical Preoperative Management Strategy

Chihjen Lee, Keira Beisel
article en

Abstract

According to the current practice guideline released on 10/29/24, most patients can continue GLP-1 RA therapy perioperatively; however, point-of-care ultrasound (POCUS) examinations have found solids or liquids retained in their stomachs despite adherence to this recommendation. While the guideline aims to streamline perioperative care, it may inadvertently increase anesthesia risk in certain patients. This paper demonstrates that many patients retain stomach contents despite discontinuing GLP-1 RA therapy for up to two weeks, and proposes a new dosing strategy to minimize anesthetic aspiration risk while limiting therapy interruption. Geometric series, exponential decline, and pharmacokinetic principles were applied to develop this schedule, based on the premise that medications are considered cleared after approximately four half-lives. Since the half-lives of semaglutide and liraglutide are approximately one week and 13 hours, respectively, we propose switching patients from semaglutide to liraglutide four weeks before surgery, then discontinuing liraglutide two days before surgery — timing that allows medication levels to decline by the full four half-lives. This strategy minimizes residual drug levels, reduces gastric retention, and lowers aspiration risk, all while limiting the overall interruption of GLP-1 RA therapy.

Cureus
Cedars-Sinai Medical Center (US), Harvard University (US)
Good health and well-being
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon